Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Burns

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Nature Reviews. Disease Primers|May 4, 2019
Myasthenia gravisNils Erik Gilhus, Socrates Tzartos, Amelia Evoli, et al.
Muscle & Nerve|July 10, 2013
Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?Donald B Sanders, Ted M Burns, Gary R Cutter, et al.
Muscle & Nerve|September 6, 2019
Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatmentGary Cutter, Haichang Xin, Inmaculada Aban, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasmElliot L Dimberg, Sheila E Crowe, Joel M Trugman, et al.
Arquivos De Neuro-Psiquiatria|December 19, 2013
Brazilian cross-cultural translation and adaptation of the "Questionnaire of Life Quality Specific for Myasthenia Gravis - 15 items"Aline Mansueto Mourão, Caroline Martins Araújo, Luiz Sérgio Mageste Barbosa, et al.
Journal of Clinical Apheresis|September 1, 2010
Clinical applications of therapeutic apheresisRasheed A Balogun, Andre Kaplan, David M Ward, et al.
Muscle & Nerve|September 7, 2023
Measuring treatment adverse event burden in myasthenia gravis: Single-center prospective evaluation utilizing the Adverse Event Unit (AEU)Michael K Hehir, Mark Conaway, Avery B St Sauveur, et al.
Plos One|February 17, 2022
The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse eventsMichael K Hehir, Mark Conaway, Eric M Clark, et al.
Revista Da Associacao Medica Brasileira (1992)|June 25, 2015
Clinical profile of patients with myasthenia gravis followed at the University Hospital, Federal University of Minas GeraisAline Mansueto Mourão, Luiz Sérgio Mageste Barbosa, Elizabeth Regina Comini-Frota, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2017
Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16)Mark Ballow, Mark R Conaway, Panida Sriaroon, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Nature Reviews. Disease Primers|May 4, 2019
Myasthenia gravisNils Erik Gilhus, Socrates Tzartos, Amelia Evoli, et al.
Muscle & Nerve|July 10, 2013
Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?Donald B Sanders, Ted M Burns, Gary R Cutter, et al.
Muscle & Nerve|September 6, 2019
Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatmentGary Cutter, Haichang Xin, Inmaculada Aban, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasmElliot L Dimberg, Sheila E Crowe, Joel M Trugman, et al.
Arquivos De Neuro-Psiquiatria|December 19, 2013
Brazilian cross-cultural translation and adaptation of the "Questionnaire of Life Quality Specific for Myasthenia Gravis - 15 items"Aline Mansueto Mourão, Caroline Martins Araújo, Luiz Sérgio Mageste Barbosa, et al.
Journal of Clinical Apheresis|September 1, 2010
Clinical applications of therapeutic apheresisRasheed A Balogun, Andre Kaplan, David M Ward, et al.
Muscle & Nerve|September 7, 2023
Measuring treatment adverse event burden in myasthenia gravis: Single-center prospective evaluation utilizing the Adverse Event Unit (AEU)Michael K Hehir, Mark Conaway, Avery B St Sauveur, et al.
Plos One|February 17, 2022
The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse eventsMichael K Hehir, Mark Conaway, Eric M Clark, et al.
Revista Da Associacao Medica Brasileira (1992)|June 25, 2015
Clinical profile of patients with myasthenia gravis followed at the University Hospital, Federal University of Minas GeraisAline Mansueto Mourão, Luiz Sérgio Mageste Barbosa, Elizabeth Regina Comini-Frota, et al.
The Journal of Allergy and Clinical Immunology|January 10, 2017
Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16)Mark Ballow, Mark R Conaway, Panida Sriaroon, et al.
Pageof 9